Pure Extracts Consolidates Hold on Canada’s Extract Sector; Receives Standard Processing Licence from Health Canada

• Pure Extracts Technologies specializes in extraction of key molecules, oils from biomass
• Extracts are used to manufacture THC & CBD oils, edibles, infused beverages
• Edible and infused beverage products have been available in Canada since late 2019, taking up 13% market share within Canada’s specialty drug market
• Pure Extracts recently awarded standard processing license by Health Canada, which will enable the Company to produce clinical trial samples in its purpose-built facilities located near Whistler, Canada

Pure Extracts Technologies, a Pemberton, British Columbia-domiciled private plant extraction company, has witnessed its fortunes rise as of late. The Company’s unique business model is founded on four key pillars, namely the extraction of key molecules and oils from biomass as a tolling service, white-label product formulation, manufacturing and sales of its own ‘Pure Pulls’ brand and sales of its new functional mushroom product line –  ‘Pure Mushrooms’. With the Canadian market for edibles and infused beverages alone estimated to amount to over $2 billion a year and rising  (https://ibn.fm/6CNsm), end product manufacturers have found themselves increasingly hard-pressed in establishing a reliable supply chain to satisfy their growing demand for raw materials. Pure Extracts in turn have found themselves ideally positioned to benefit from the ongoing explosion in demand.

Pure Extracts’ current operations combine the Company’s legacy cannabis and hemp tolling experience, which seeks to convert hemp biomass into extracts such as CBD oil, distillates and isolates, with a growing product development operation which has . . . 

Read More >>

NOTE TO INVESTORS: The latest news and updates relating to Pure Extracts are available in the company’s newsroom at http://ibn.fm/Pure

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.PsychedelicNewsWire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
[email protected]

PsychedelicNewsWire is part of the InvestorBrandNetwork.